FDA Allowed Release Of Moderna COVID Booster While Still Mulling Plant Inspection Findings

 
• By Bowman Cox

Memo outlines how US agency ensured sufficient delivery of updated COVID-19 vaccine doses even as it navigated unresolved inspection findings of the Catalent plant where the additional doses had been manufactured.

COVID vaccine filling
fda: batch investigations were inadequate, but these batches look good • Source: Shutterstock

More from Vaccines

More from Pink Sheet